← back to search

Wen‐Di Li

Shandong University · CN
Area of research
Biomedical Engineering · Electrical and Electronic Engineering
Research interest
Research interests include Biology, Cell growth, Cancer research, ATRX, Telomere, and Death-associated protein 6.
h-index
citations
953
works
8
NIH funding
primary concept
email

Recent publications

Perovskite heteroepitaxy for high-efficiency and stable pure-red LEDs
Nature 2025cited by 110position: middledoi
KBU2046 exerts inhibition on chemokine gradient-mediated motility of esophageal squamous cell carcinoma through reducing integrin expression
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025cited by 0position: middledoi
Agrivoltaics development progresses: From the perspective of photovoltaic impact on crops, soil ecology and climate
Environmental Research 2024cited by 27position: middledoi
Field-free spin–orbit torque switching in <i>L</i>1-FePt single layer with tilted anisotropy
Applied Physics Letters 2022cited by 49position: middledoi
lnc-Rps4l-encoded peptide RPS4XL regulates RPS6 phosphorylation and inhibits the proliferation of PASMCs caused by hypoxia
Molecular Therapy 2021cited by 39position: middledoi
Circular RNA hsa_circ_101555 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-145-5p and regulating CDCA3 expression
Cell Death and Disease 2021cited by 34position: middledoi
Puerarin prevents progression of experimental hypoxia-induced pulmonary hypertension via inhibition of autophagy
Journal of Pharmacological Sciences 2019cited by 37position: middledoi
RstA, a two-component response regulator, plays important roles in multiple virulence-associated processes in enterohemorrhagic Escherichia coli O157:H7
Gut Pathogens 2019cited by 31position: middledoi
Characterization of a strong and constitutive promoter from the Arabidopsis serine carboxypeptidase-like gene AtSCPL30 as a potential tool for crop transgenic breeding
BMC Biotechnology 2018cited by 72position: middledoi
Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
PLoS Genetics 2012cited by 634position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xijuan Zhao · Harbin Medical University2 papers (2021–2021)Xiufeng Yu · Harbin Medical University2 papers (2021–2021)Daling Zhu · Ministry of Education of the People's Republic of China2 papers (2019–2021)Xiaoguang Gu · Harbin Medical University1 papers (2021–2021)Elena V. Ivanova · Brigham and Women's Hospital1 papers (2012–2012)Bert Vogelstein · Clinical Pharmacology of Miami1 papers (2012–2012)Tong Zhou · Shandong University of Technology1 papers (2025–2025)Yajuan Ran · Harbin Medical University1 papers (2021–2021)Xinliang Fu · First Automotive Works (China)1 papers (2025–2025)Mingjian Yuan · Nankai University1 papers (2025–2025)Yongxian Xue · Hebei Medical University1 papers (2025–2025)Keyu Wei · Hebei Medical University1 papers (2025–2025)Mohammad Khaja Nazeeruddin · University of Lausanne1 papers (2025–2025)Laura E. MacConaill · Brigham and Women's Hospital1 papers (2012–2012)Maria Jasin · Kettering University1 papers (2012–2012)Wen Cheng · Yale Cancer Center1 papers (2018–2018)Yuchen Jiao · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2012–2012)Kexin Li · Shenyang Pharmaceutical University1 papers (2025–2025)Huihui Li · Tianjin University of Traditional Chinese Medicine1 papers (2022–2022)Yang Liu · National University of Singapore1 papers (2022–2022)